Literature DB >> 10400740

A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12(I) protein greatly influences its stability.

R Trovato1, J C Mulloy, J M Johnson, S Takemoto, M P de Oliveira, G Franchini.   

Abstract

The HTLV-1 singly spliced open reading frame I protein, p12(I), is highly unstable and appears to be necessary for persistent infection in rabbits. Here we demonstrate that p12(I) forms dimers through two putative leucine zipper domains and that its stability is augmented by specific proteasome inhibitors. p12(I) is ubiquitylated, and mutations of its unique carboxy-terminus lysine residue to an arginine greatly enhance its stability. Interestingly, analysis of 53 independent HTLV-1 strains revealed that the natural p12(I) alleles found in ex vivo samples of tropical spastic paraparesis-HTLV-1-associated myelopathy patients contain a Lys at position 88 in some cases, whereas arginine is consistently found at position 88 in HTLV-1 strains from all adult T-cell leukemia-lymphoma (ATLL) cases and healthy carriers studied. This apparent segregation of different alleles in tropical spastic paraparesis-HTLV-associated myelopathy and ATLL or healthy carriers may be relevant in vivo, since p12(I) binds the interleukin-2 receptor beta and gammac chains, raising the possibility that the two natural alleles might affect differently the regulation of these molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400740      PMCID: PMC112727     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1.

Authors:  O Schwartz; V Maréchal; B Friguet; F Arenzana-Seisdedos; J M Heard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 2.  Virocrine transformation: the intersection between viral transforming proteins and cellular signal transduction pathways.

Authors:  D DiMaio; C C Lai; O Klein
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

3.  The ubiquitin system.

Authors:  A Varshavsky
Journal:  Trends Biochem Sci       Date:  1997-10       Impact factor: 13.807

4.  X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro.

Authors:  D Derse; J Mikovits; F Ruscetti
Journal:  Virology       Date:  1997-10-13       Impact factor: 3.616

5.  Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes.

Authors:  M D Robek; F H Wong; L Ratner
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Reversal of fortune for nascent proteins.

Authors:  J S Bonifacino
Journal:  Nature       Date:  1996-12-05       Impact factor: 49.962

Review 7.  ER quality control: the cytoplasmic connection.

Authors:  R R Kopito
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

8.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 9.  Human T cell leukemia virus type I (HTLV-I) and human diseases.

Authors:  T Uchiyama
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

10.  Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo.

Authors:  N D Collins; G C Newbound; B Albrecht; J L Beard; L Ratner; M D Lairmore
Journal:  Blood       Date:  1998-06-15       Impact factor: 22.113

View more
  22 in total

1.  Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.

Authors:  J M Johnson; C Nicot; J Fullen; V Ciminale; L Casareto; J C Mulloy; S Jacobson; G Franchini
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 2.  Lessons from viral manipulation of protein disposal pathways.

Authors:  Margo H Furman; Hidde L Ploegh
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 3.  Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.

Authors:  Michael D Lairmore; Lee Silverman; Lee Ratner
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

Review 4.  Hijacking the T-cell communication network by the human T-cell leukemia/lymphoma virus type 1 (HTLV-1) p12 and p8 proteins.

Authors:  Nancy Van Prooyen; Vibeke Andresen; Heather Gold; Izabela Bialuk; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  Mol Aspects Med       Date:  2010-07-29

5.  First report of HTLV-1 truncated p12 protein in Brazil.

Authors:  Carolina Rosadas; Ana C P Vicente; Louise Zanella; Mauro J Cabral-Castro; José M Peralta; Marzia Puccioni-Sohler
Journal:  Virulence       Date:  2016-12-14       Impact factor: 5.882

6.  Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin.

Authors:  W Ding; B Albrecht; R Luo; W Zhang; J R Stanley; G C Newbound; M D Lairmore
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

7.  HTLV-1 proviruses encoding non-functional TAX in adult T-cell leukemia.

Authors:  S Okazaki; R Moriuchi; N Yosizuka; K Sugahara; T Maeda; I Jinnai; M Tomonaga; S Kamihira; S Katamine
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

Review 8.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

Review 9.  Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.

Authors:  Björn Albrecht; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

Review 10.  Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.

Authors:  Michael Bindhu; Amrithraj Nair; Michael D Lairmore
Journal:  Front Biosci       Date:  2004-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.